Skip to main content
. 2019 Jun 11;10:604. doi: 10.3389/fneur.2019.00604

Figure 3.

Figure 3

Low serum IL-10 levels are a predictor of relapse for clinically isolated syndrome (CIS) patients. (A) There was a significantly higher proportion of patients with clinical relapse (R) during follow-up among low IL-10 (<1.3 pg/ml) CIS patients than among high IL-10 (≥1.3 pg/ml) CIS patients (70.0 vs. 30.0%, p < 0.001). (B) Kaplan–Meier curves show that the time to first relapse was shorter in CIS patients with low serum levels of IL-10 (log-rank, p = 0.001).